India, Jan. 14 -- Weight loss drugs such as Ozempic, Wegovy (Semaglutide), and Mounjaro (Tirzepatide), have brought a spotlight on the growing health crisis of obesity and diabetes. A recent study in The British Medical Journal (BMJ) reported that after completing clinical trials and following patients for 6-8 months, weight regain of 7-8% occurred when Semaglutide was discontinued. This has increased concerns about maintaining weight loss after discontinuing weight loss drugs.

When you stop taking GLP-1 medications, you may regain weight. To understand why, you must first understand the mechanism of these medications to boost weight loss. These weight loss drugs mimic the natural hormone GLP-1, which helps control appetite and slows sto...